{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:06:51Z","timestamp":1789679211825,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacl.2026.08.022","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:13:35Z","timestamp":1788448415000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of complex lipid disorders in a community lipid clinic setting: Implementing a multidisciplinary model"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-2815","authenticated-orcid":false,"given":"Michael I.","family":"Miyamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-4514","authenticated-orcid":false,"given":"Carol","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ting","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace S.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Coy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sainaz","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur H.","family":"Loussararian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"El-Haj-Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.08.022_bib1","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1161\/CIR.0000000000001457","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"153","author":"Blumenthal","year":"2026","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jacl.2026.08.022_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2022.12567","article-title":"Trends in lipid concentrations and lipid control among US adults, 2007-2018","volume":"328","author":"Aggarwal","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jacl.2026.08.022_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacl.2019.07.011","article-title":"JCL roundtable: lipid clinic operations","volume":"13","author":"Liebeskind","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.022_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2026.120757","article-title":"Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics","volume":"418","author":"Bork","year":"2026","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jacl.2026.08.022_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jacl.2022.05.068","article-title":"NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient","volume":"16","author":"Cheeley","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"25","key":"10.1016\/j.jacl.2026.08.022_bib6","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.jacl.2026.08.022_bib7","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"25 2","key":"10.1016\/j.jacl.2026.08.022_bib8","first-page":"S1","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.jacl.2026.08.022_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and treatment of heterozygous familial hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"34","key":"10.1016\/j.jacl.2026.08.022_bib10","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","article-title":"Prevalence of statin intolerance: a meta-analysis","volume":"43","author":"Byty\u00e7i","year":"2022","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacl.2026.08.022_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jacc.2015.05.030","article-title":"Utilization of and adherence to guideline-recommended lipid-lowering therapy after acute coronary syndrome: opportunities for improvement","volume":"66","author":"Hirsh","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.jacl.2026.08.022_bib12","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 trial of a statin, placebo, or no treatment to assess side effects","volume":"383","author":"Wood","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jacl.2026.08.022_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jacl.2022.09.001","article-title":"Assessment and management of statin-associated muscle symptoms (SAMS): a clinical perspective from the National Lipid Association","volume":"17","author":"Warden","year":"2023","journal-title":"J Clin Lipidol"},{"issue":"11","key":"10.1016\/j.jacl.2026.08.022_bib14","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1111\/bcp.15438","article-title":"Statin-related adverse drug reactions in UK primary care consultations: a retrospective cohort study to evaluate the risk of cardiovascular events and all-cause mortality","volume":"88","author":"Insani","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.jacl.2026.08.022_bib15","article-title":"Quantification of utilization management barriers for patients initiating therapy to lower lipid levels","volume":"5","author":"O'Neil","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacl.2026.08.022_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2026.07.017","article-title":"Comparative efficacy of different statin intensities combined with ezetimibe on lipid profile improvement in patients with coronary heart disease: a network meta-analysis","author":"Niu","year":"2026","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.jacl.2026.08.022_bib17","first-page":"737","article-title":"Multidisciplinary teams in clinical lipidology and cardiometabolic care: a National Lipid Association Expert Clinical Review","volume":"19","author":"Cheeley","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"6","key":"10.1016\/j.jacl.2026.08.022_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11883-023-01096-0","article-title":"Medical nutrition therapy provided by dietitians is effective and saves healthcare costs in the management of adults with dyslipidemia","volume":"25","author":"Sikand","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2026.08.022_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2023.04.003","article-title":"Genetic testing increases the likelihood of a diagnosis of familial hypercholesterolaemia among people referred to lipid clinics: Danish national study","volume":"373","author":"Hedegaard","year":"2023","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jacl.2026.08.022_bib20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jgc4.1050","article-title":"The impact of cardiovascular genetic counseling on patient empowerment","volume":"28","author":"Ison","year":"2019","journal-title":"J Genet Couns"},{"issue":"4","key":"10.1016\/j.jacl.2026.08.022_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10897-017-0175-7","article-title":"Clinical cardiovascular genetic counselors take a leading role in team-based variant classification","volume":"27","author":"Reuter","year":"2018","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jacl.2026.08.022_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101826","article-title":"Prevalence and correlates of lipoprotein(a) testing in a diverse cohort of U.S. adults","volume":"4","author":"Razavi","year":"2025","journal-title":"JACC Adv"},{"issue":"3","key":"10.1016\/j.jacl.2026.08.022_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacl.2025.12.016","article-title":"Country-specific prevalence and clinical relevance of elevated Lp(a) as a risk enhancer in 2 Greek cohorts","volume":"20","author":"Delialis","year":"2026","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.jacl.2026.08.022_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.5585","article-title":"Trends and disparities in the use of next-generation sequencing in patients with cancer in the United States","volume":"9","author":"Hage Chehade","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"24","key":"10.1016\/j.jacl.2026.08.022_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001385","article-title":"Genetic and genomic testing in cardiovascular disease: a policy statement from the American Heart Association","volume":"152","author":"Landstrom","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.08.022_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1161029","article-title":"Evolving cardiovascular genetic counseling needs in the era of precision medicine","volume":"10","author":"Morales","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.jacl.2026.08.022_bib27","article-title":"Strategy to reduce >350 000 yearly deaths from atherosclerotic coronary artery disease by 2050 in the United States","volume":"19","author":"Ziaeian","year":"2026","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426005003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426005003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:57:46Z","timestamp":1789678666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426005003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"alternative-id":["S1933287426005003"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.08.022","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of complex lipid disorders in a community lipid clinic setting: Implementing a multidisciplinary model","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}